Download PDF
Zentralbl Gynakol 2003; 125(6): 195-201
DOI: 10.1055/s-2003-42601
Übersicht

© Georg Thieme Verlag Stuttgart · New York

Phytoöstrogene

PhytoestrogensA. Zittermann1
  • 1Institut für Ernährungswissenschaft, Universität Bonn
Further Information

Publication History

Publication Date:
10 October 2003 (online)

    Permissions and Reprints

Zusammenfassung

Zu den Phytoöstrogenen werden u. a. die Soja-Isoflavone Genistein und Daidzein sowie die Lignane Secoisolariciresinol und Matairesinol aus Leinsamen gezählt. Aufgrund epidemiologischer Daten wird den Pytoöstrogenen eine protektive Wirkung gegenüber verschiedenen Östrogen-abhängigen Erkrankungen/Beschwerden wie Brustkrebs, Menopausensymptome, kardiovaskuläre Erkrankungen und Osteoporose zugeschrieben. Um diese Vermutung zu überprüfen, wurden eine Reihe derzeit verfügbarer kontrollierter klinischer Studien ausgewertet. Insbesondere zu den Soja-Isoflavonen liegen umfangreiche Daten vor. Es ergaben sich keine Belege für einen Einfluss der Isoflavone auf Menopausensymptome und Risikofaktoren für Brustkrebs. Isoflavon-haltiges Sojaprotein kann allerdings den Serumspiegel an Gesamt-Cholesterol, LDL-Cholesterol und Triglyzeriden senken. Die stärksten Beweise existieren bezüglich einer präventiven Wirkung von Soja-Isoflavonen gegenüber dem postmenopausalen Knochenabbau an der Lendenwirbelsäule. Die unterschiedlichen Effekte auf Östrogen-abhängige Erkrankungen/Beschwerden können zumindest teilweise durch Differenzen in der Bindungsfähigkeit von Isoflavonen an den Östrogenrezeptor α und β und durch Unterschiede in der Gewebsverteilung dieser Rezeptoren erklärt werden.

Abstract

The soy-isoflavones genistein and daidzein and the flaxseed-lignans secoisolariciresinol and matairesinol belong to the group of phytoestrogens. Epidemiological data suggest that phytoestrogens have a preventive effect against various estrogen-related diseases/symptoms such as breast cancer, menopausal symptoms, cardiovascular diseases, and osteoporosis. To prove these assumptions, available controlled clinical trials have been critically reviewed. Especially soy-isoflavones have been extensively studied. There is no scientific evidence for an effect of phytoestrogens on menopausal symptoms and risk factors of breast cancer. However, isoflavones-containing soy protein can lower total cholesterol, LDL cholesterol, and triglyceride serum levels. The strongest evidence exists for a preventive effect of soy isoflavones on postmenopausal bone loss of the lumbar spine. Distinct effects on estrogen-related diseases can be explained at least in part by the different affinity of isoflavones to estrogen receptors α and β and the distinct tissue distribution of these receptors.

Schlüsselwörter

Phytoöstrogene - Isoflavone - Soja - Rotklee - Lignane

Key words

Phytoestrogens - isoflavones - soy - red clover - lignans

Literatur

  • 1 Wang H, Murphy P A. Isoflavone composition of American and Japanese soybeans in Iowa: effects of variety, crop year, and location.  J Agric Food Chem. 1994;  42 1674-1677
    CrossrefPubMedGoogle Scholar
  • 2 Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases.  Ann Med. 1997;  29 95-120
    CrossrefPubMedGoogle Scholar
  • 3 Lissin L W, Cooke J P. Phytoestrogens and cardiovascular health.  J Am Coll Cardiol. 2000;  35 1403-1410
    CrossrefPubMedGoogle Scholar
  • 4 Xu X, Harris K S, Wang H J, Murphy P A, Hendrich S. Bioavailability of soybean isoflavones depends upon gut microflora in women.  J Nutr. 1995;  125 2307-2315
    PubMedGoogle Scholar
  • 5 King R A, Bursill D B. Plasma and urinary kinetics of the isoflavones daidzein and genistein after a single soy meal in humans.  Am J Clin Nutr. 1998;  67 867-872
    PubMedGoogle Scholar
  • 6 Xu X, Wang H J, Murphy P A, Cook L, Hendrich S. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women.  J Nutr. 1994;  124 825-832
    PubMedGoogle Scholar
  • 7 Setchell K D, Brown N M, Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.  J Nutr. 2002;  132 3577-3584
    PubMedGoogle Scholar
  • 8 Nesbitt P D, Lam Y, Thompson L U. Human metabolism of mammalian lignan precursors in raw and processed flaxseed.  Am J Clin Nutr. 1999;  69 549-555
    PubMedGoogle Scholar
  • 9 Kuiper G GJM, Lemmen J G, Carlsson B, Corton C, Safe S H, van der Saag P T, van der Burg B, Gustafsson J A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor ß.  Endocrinology. 1998;  139 4252-4263
    CrossrefPubMedGoogle Scholar
  • 10 Morito K, Hirose T, Kinjo J, Hirakawa T, Okawa M, Nohara T, Ogawa S, Inoue S, Muramatsu M, Masamune Y. Interaction of phytoestrogens with estrogen receptors alpha and beta.  Biol Pharm Bull. 2001;  24 351-356
    CrossrefPubMedGoogle Scholar
  • 11 Ringe J D, Nickelsen T. Raloxifen.  Arzneimitteltherapie. 1999;  17 113-120
    PubMedGoogle Scholar
  • 12 Okura A, Arakawa H, Oka H, Yoshinari T, Monden Y. Effect of genistein on topoisomerase activity and on the growth of [Val 12]Ha-ras-transformed NIH 3T3 cells.  Biochem Biophys Res Commun. 1988;  157 183-189
    CrossrefPubMedGoogle Scholar
  • 13 Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases.  J Biol Chem. 1987;  262 5592-5595
    PubMedGoogle Scholar
  • 14 Wei H, Bowen R, Cai Q, Barnes S, Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein.  Proc Soc Exp Biol Med. 1995;  208 124-130
    PubMedGoogle Scholar
  • 15 Saarinen N M, Warri A, Makela S I, Eckerman C, Reunanen M, Ahotupa M, Salmi S M, Franke A A, Kangas L, Santti R. Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies).  Nutr Cancer. 2000;  36 207-216
    PubMedGoogle Scholar
  • 16 Parkin D M, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000.  Int J Cancer. 2001;  94 153-156
    CrossrefPubMedGoogle Scholar
  • 17 Treloar A E, Boynton R E, Behn B G, Brown B W. Variation of the human menstrual cycle through reproductive life.  Int J Fertil. 1967;  12 77-126
    PubMedGoogle Scholar
  • 18 Henderson B E, Ross R K, Judd H L, Krailo M D, Pike M C. Do regular ovulatory cycles increase breast cancer risk?.  Cancer. 1985;  56 1206-1208
    CrossrefPubMedGoogle Scholar
  • 19 Goldin B R, Adlercreutz H, Gorbach S L, Woods M N, Dwyer J T, Conlon T, Bohn E, Gershoff S N. The relationship between estrogen levels and diets of Caucasian American and Oriental immigrant women.  Am J Clin Nutr. 1986;  44 945-953
    PubMedGoogle Scholar
  • 20 Duncan A M, Merz B E, Xu X, Nagel T C, Phipps W R, Kurzer M S. Soy isoflavones exert modest hormonal effects in premenopausal women.  J Clin Endocrinol Metab. 1999;  84 192-197
    CrossrefPubMedGoogle Scholar
  • 21 Lu L J, Anderson K E, Grady J J, Nagamani M. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction.  Cancer Epidemiol Biomarkers Prev. 1996;  5 63-70
    PubMedGoogle Scholar
  • 22 Lu L J, Anderson K E, Grady J J, Kohen F, Nagamani M. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention.  Cancer Res. 2000;  60 4112-4121
    PubMedGoogle Scholar
  • 23 Nagata C, Takatsuka N, Inaba S, Kawakami N, Shimizu H. Effect of soymilk consumption on serum estrogen concentrations in premenopausal Japanese women.  J Natl Cancer Inst. 1998;  90 1830-1835
    CrossrefPubMedGoogle Scholar
  • 24 Petrakis N L, Barnes S, King E B, Lowenstein J, Wiencke J, Lee M M, Miike R, Kirk M, Coward L. Stimulatory influence of soy protein isolate on breast secretion in pre­and ostmenopausal women.  Cancer Epidemiol Biomarkers Prev. 1996;  5 785-794
    PubMedGoogle Scholar
  • 25 Cassidy A, Bingham S, Setchell K D. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women.  Am J Clin Nutr. 1994;  60 333-340
    PubMedGoogle Scholar
  • 26 Kurzer M S. Hormonal effects of soy in premenopausal women and men.  J Nutr. 2002;  132 570S-573S
    PubMedGoogle Scholar
  • 27 Lamartiniere C A, Cotroneo M S, Fritz W A, Wang J, Mentor-Marcel R, Elgavish A. Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate.  J Nutr. 2002;  132 5525-558S
    PubMedGoogle Scholar
  • 28 Knight D C, Howes J B, Eden J A. The effect of Promensil, an isoflavone extract, on menopausal symptoms.  Climacteric. 1999;  2 79-84
    PubMedGoogle Scholar
  • 29 Baber R J, Templeman C, Morton T, Kelly G E, West L. Randomized placebocontrolled trial of an isoflavone supplement and menopausal symptoms in women.  Climacteric. 1999;  2 85-92
    PubMedGoogle Scholar
  • 30 Kotsopoulos D, Dalais F S, Liang Y L, McGrath B P, Teede H J. The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women.  Climacteric. 2000;  3 161-167
    PubMedGoogle Scholar
  • 31 Knight D C, Howes J B, Eden J A, Howes L G. Effects on menopausal symptoms and acceptability of isoflavone-containing soy powder dietary supplementation.  Climacteric. 2001;  4 13-18
    PubMedGoogle Scholar
  • 32 St Germain A, Peterson C T, Robinson J G, Alekel D L. Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment.  Menopause. 2001;  8 17-26
    PubMedGoogle Scholar
  • 33 Dalais F S, Rice G E, Wahlqvist M L, Grehan M, Murkies A L, Medley G, Ayton R, Strauss B J. Effects of dietary phytoestrogens in postmenopausal women.  Climacteric. 1998;  1 124-129
    PubMedGoogle Scholar
  • 34 Washburn S, Burke G L, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women.  Menopause. 1999;  6 7-13
    PubMedGoogle Scholar
  • 35 Han K K, Soares Jr J M, Haidar M A, de Lima G R, Baracat E C. Benefits of soy isoflavone therapeutic regimen on menopausal symptoms.  Obstet Gynecol. 2002;  99 389-394
    CrossrefPubMedGoogle Scholar
  • 36 Fankhänel S. Soja and Gesundheit.  Ernährungs-Umschau. 2000;  47 159-163
    PubMedGoogle Scholar
  • 37 Anderson J JB, Johnstone B M, Cook-Newell M E. Meta- analysis of the effects of soy protein intake on serum lipids.  New Engl J Med. 1995;  333 276-282
    CrossrefPubMedGoogle Scholar
  • 38 Clarkson T B, Anthony M S. Phytoestrogens and coronary heart disease.  Balliere's Clin Endocrinol Metab. 1998;  12 589-604
    PubMedGoogle Scholar
  • 39 Merz-Demlow B E, Duncan A M, Wangen K E, Xu X, Carr T P, Phipps W R, Kurzer M S. Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women.  Am J Clin Nutr. 2000;  71 1462-1469
    PubMedGoogle Scholar
  • 40 Anthony M S, Clarkson T B, Williams J K. Effects of soy isoflavones on atherosclerosis: potential mechanisms.  Am J Clin Nutr. 1998;  68 1390S-1393S
    PubMedGoogle Scholar
  • 41 Potter S M, Baum J A, Teng H, Stillmann R J, Shay N F, Erdman J W. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women.  Am J Clin Nutr. 1998;  68 1375S-1379S
    PubMedGoogle Scholar
  • 42 Huff M W, Roberts D C, Carroll K K. Long-term effects of semipurified diets containing casein or soy protein isolate on atherosclerosis and plasma lipoproteins in rabbits.  Atherosclerosis. 1982;  41 327-336
    PubMedGoogle Scholar
  • 43 Polkowski K, Mazurek A P. Biological properties of genistein. A review of in vitro and in vivo data.  Acta Poloniae Pharmaceutica - Drug Research. 2000;  57 135-155
    PubMedGoogle Scholar
  • 44 Howes J B, Sullivan D, Lai N, Nestel P, Pomeroy S, West L, Eden J A, Howes L G. The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia.  Atherosclerosis. 2000;  152 143-147
    CrossrefPubMedGoogle Scholar
  • 45 Lemay A, Dodin S, Kadri N, Jacques H, Forest J C. Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women.  Obstet Gynecol. 2002;  100 495-504
    CrossrefPubMedGoogle Scholar
  • 46 Lucas E A, Wild R D, Hammond L J, Khalil D A, Juma S, Daggy B P, Stoecker B J, Arjmandi B H. Flaxseed improves lipid profile without altering biomarkers of bone metabolism in postmenopausal women.  J Clin Endocrinol Metab. 2002;  87 1527-1532
    CrossrefPubMedGoogle Scholar
  • 47 Jenkins D J, Kendall C W, Vidgen E, Agarwal S, Rao A V, Rosenberg R S, Diamandis E P, Novokmet R, Mehling C C, Perera T, Griffin L C, Cunnane S C. Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial.  Am J Clin Nutr. 1999;  69 395-402
    CrossrefPubMedGoogle Scholar
  • 48 Nestel P J, Pomeroy S, Kay S, Komesaroff P, Behrsing J, Cameron J D, West L. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women.  J Clin Endocrinol Metab. 1999;  84 895-898
    CrossrefPubMedGoogle Scholar
  • 49 Horiuchi T, Onouchi T, Takahashi M, Ito H, Orimo H. Effect of soy protein on bone metabolism in postmenopausal Japanese women.  Osteoporos Int. 2000;  11 721-724
    CrossrefPubMedGoogle Scholar
  • 50 Ho S C, Chan S G, Yi Q, Wong E, Leung P C. Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women.  J Bone Miner Res. 2001;  16 1363-1369
    PubMedGoogle Scholar
  • 51 Somekawa Y, Chiguchi M, Ishibachi T, Aso T. Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women.  Obstet Gynecol. 2001;  97 109-115
    CrossrefPubMedGoogle Scholar
  • 52 Alekel D L, Germain A S, Peterson C T, Hanson K B, Stewart J W, Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women.  Am J Clin Nutr. 2000;  72 844-852
    CrossrefPubMedGoogle Scholar
  • 53 Morabito N, Crisafulli A, Vergara C, Gaudio A, Lasco A, Frisina N, D'Anna R, Corrado F, Pizzoleo M A, Cincotta M, Altavilla D, Ientile R, Squadrito F. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind placebo-controlled study.  J Bone Miner Res. 2002;  17 1904-1912
    PubMedGoogle Scholar
  • 54 Williams J P, Jordan S E, Barnes S, Blair H C. Tyrosine kinase inhibitor effects on avian osteoclastic acid transport.  Am J Clin Nutr. 1998;  68 1369S-1374S
    PubMedGoogle Scholar
  • 55 Yamaguchi M, Sugimoto E. Stimulatory effect of genistein and daidzein on protein synthesis in osteoblastic MC3T3-E1 cells: activation of aminoacyl-tRNA synthetase.  Mol Cell Biochem. 2000;  214 97-102
    CrossrefPubMedGoogle Scholar
  • 56 Mei J, Yeung S S, Kung A W. High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women.  J Clin Endocrinol Metab. 2001;  86 5217-5221
    CrossrefPubMedGoogle Scholar
  • 57 Clifton-Bligh P B, Baber R J, Fulcher G R, Nery M L, Moreton T. The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism.  Menopause. 2001;  8 259-265
    PubMedGoogle Scholar
  • 58 Wisker E, Rabe E, Metzner C, Feldheim W. Zur Wirksamkeit von Leinsamen.  Ernährungs-Umschau. 1999;  46 76-81
    PubMedGoogle Scholar

Priv. Doz. Dr. oec. troph. Armin Zittermann

Institut für Ernährungswissenschaft · Universität Bonn

Endenicher Allee 11-13

53115 Bonn

Phone: 02 28/73 20 16

Fax: 02 28/73 32 17

Email: a.zittermann@uni-bonn.de

      >